Jean Philippe Annereau

Jean Philippe ANNEREAU has experience as a CEO and co-founder at Medetia Pharmaceuticals, focusing on new therapeutics for rare and severe renal diseases. Jean Philippe is also a co-founder and board member at AtmosR. Previously, Jean Philippe served as the Site Director and President at Alexion R&D France and held a leadership position at Pierre Fabre. Jean Philippe pursued their Ph.D at Ecole Polytechnique and studied at Paris-Sud University.